Skip to main content
Log in

Alanyl-Glutamine and Glutamine Supplementation Improves 5-Fluorouracil-Induced Intestinal Epithelium Damage In Vitro

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

In this study, we have examined the role of glutamine derivatives in reducing 5-fluorouracil (5-FU)-induced epithelial damage in an undifferentiated crypt intestinal cell line, IEC-6. In this model, we have investigated proliferation indirectly by detecting the enzyme-derived formazan dye from the tetrazolium salt WST-1 in viable cells at 24 and 48 h after 5-FU treatment. Migration was measured at 12 and 24 h after razor scraping of the cell monolayer. Cell death was measured by quantifying the percentage of apoptotic and necrotic figures by flow cytometry at 12 and 24 h following 5-FU challenge. Neither glutamine nor alanyl-glutamine prevented 5-FU-induced apoptosis and necrosis in IEC-6 cells at 12 and 24 h after 5-FU challenge. However, glutamine and alanyl-glutamine enhanced migration and proliferation when compared with 5-FU-treated controls (< 0.05). These new findings support our earlier study on the benefit of oral glutamine in enhancing epithelial recovery after 5-FU challenge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Potten CS (1975) Kinetics and possible regulation of crypt cell populations under normal and stress conditions. Bull Cancer 62:419–430

    PubMed  CAS  Google Scholar 

  2. Potten CS (1986) Cell cycles in cell hierarchies. Int J Radiat Biol Relat Stud Phys Chem Med 49:257–278

    Article  PubMed  CAS  Google Scholar 

  3. Potten CS, Booth C (1997) The role of radiation-induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol B Biochem Mol Biol 118:473–478

    Article  PubMed  CAS  Google Scholar 

  4. Clatworthy JP, Subramanian V (2001) Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies. Mech Dev 101:3–9

    Article  PubMed  CAS  Google Scholar 

  5. Roncucci L, Pedroni M, Vaccina F, Benatti P, Marzona L, De PA (2000) Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics. Cell Prolif 33:1–18

    Article  PubMed  CAS  Google Scholar 

  6. Becciolini A, Balzi M, Fabbrica D, Potten CS (1996) Cell kinetics in rat small intestine after exposure to 3 Gy of gamma-rays at different times of the day. Int J Radiat Biol 70:281–288

    Article  PubMed  CAS  Google Scholar 

  7. Naughton PJ, Grant G, Ewen SW, Spencer RJ, Brown DS, Pusztai A, Bardocz S (1995) Salmonella typhimurium and Salmonella enteritidis induce gut growth and increase the polyamine content of the rat small intestine in vivo. FEMS Immunol Med Microbiol 12:251–258

    Article  PubMed  CAS  Google Scholar 

  8. Kelder W, Hospers GA, Plukker JT (2006) Effects of 5-fluorouracil adjuvant treatment of colon cancer. Expert Rev Anticancer Ther 6:785–794

    Article  PubMed  CAS  Google Scholar 

  9. Beretta GD, Milesi L, Pessi MA, Mosconi S, Labianca R (2004) Adjuvant treatment of colorectal cancer. Surg Oncol 13:63–73

    Article  PubMed  Google Scholar 

  10. Daniele B, Secondulfo M, De VR, Pignata S, De ML, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228–230

    Article  PubMed  CAS  Google Scholar 

  11. Duncan M , Grant G (2003) Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18:853–874

    Article  PubMed  CAS  Google Scholar 

  12. Cynober LA (2002) Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18:761–766

    Article  PubMed  CAS  Google Scholar 

  13. Oehler R, Roth E (2003) Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care 6:277–282

    Article  PubMed  CAS  Google Scholar 

  14. Neu J, DeMarco V, Li N (2002) Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 5:69–75

    Article  PubMed  CAS  Google Scholar 

  15. O’Connell MJ (2004) Current status of adjuvant therapy for colorectal cancer. Oncology (Williston Park) 18:751–755

    Google Scholar 

  16. Elia M, Lunn PG (1997) The use of glutamine in the treatment of gastrointestinal disorders in man. Nutrition 13:743–747

    Article  PubMed  CAS  Google Scholar 

  17. Carneiro-Filho BA, Lima IP, Araujo DH, Cavalcante MC, Carvalho GH, Brito GA, Lima V, Monteiro SM, Santos FN, Ribeiro RA, Lima AA (2004) Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 49:65–72

    Article  PubMed  CAS  Google Scholar 

  18. Daniele B, Perrone F, Gallo C, Pignata S, De MS, De VR, Barletta E, Tambaro R, Abbiati R, D’Agostino L (2001) Oral glutamine in the prevention of fluorouracil induced intestinal toxicity a double blind, placebo controlled, randomised trial. Gut 48:28–33

    Article  PubMed  CAS  Google Scholar 

  19. Yalcin SS, Yurdakok K, Tezcan I, Oner L (2004) Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in children with acute diarrhea. J Pediatr Gastroenterol Nutr 38:494–501

    Article  PubMed  CAS  Google Scholar 

  20. Lima AA, Guerrant RL (2005) Glutamine for childhood malnutrition: is it needed? J Pediatr Gastroenterol Nutr 40:526–527

    Article  PubMed  Google Scholar 

  21. Carneiro-Filho BA, Bushen OY, Brito GA, Lima AA, Guerrant RL (2003) Glutamine analogues as adjunctive therapy for infectious diarrhea. Curr Infect Dis Rep 5:114–119

    Article  PubMed  Google Scholar 

  22. Kelly D, Wischmeyer PE (2003) Role of L-glutamine in critical illness: new insights. Curr Opin Clin Nutr Metab Care 6:217–222

    Article  PubMed  CAS  Google Scholar 

  23. Furst P (2001) New developments in glutamine delivery. J Nutr 131:2562S–2568S

    PubMed  CAS  Google Scholar 

  24. Buchman AL (1999) Glutamine for the gut: mystical properties or an ordinary amino acid? Curr Gastroenterol Rep 1:417–423

    Article  PubMed  CAS  Google Scholar 

  25. Carneiro-Filho BA, Oria RB, Wood RK, Brito GA, Fujii J, Obrig T, Lima AA, Guerrant RL (2004) Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition 20:934–941

    Article  PubMed  CAS  Google Scholar 

  26. Miller AL (1999) Therapeutic considerations of L-glutamine: a review of the literature. Altern Med Rev 4:239–248

    PubMed  CAS  Google Scholar 

  27. Hirata K, Horie T (2003) Stimulation of intestinal epithelial restitution by prostaglandin E(1) analogue. Cancer Chemother Pharmacol 51:216–220

    PubMed  CAS  Google Scholar 

  28. McCormack SA, Viar MJ, Johnson LR (1992) Migration of IEC-6 cells: a model for mucosal healing. Am J Physiol 263:G426–G435

    PubMed  CAS  Google Scholar 

  29. Daniele B, Secondulfo M, De VR, Pignata S, De ML, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32:228–230

    Article  PubMed  CAS  Google Scholar 

  30. Fata F, Ron IG, Kemeny N, O’Reilly E, Klimstra D, Kelsen DP (1999) 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer 86:1129–1134

    Article  PubMed  CAS  Google Scholar 

  31. Potten CS (1998) Stem cells in gastrointestinal epithelium: numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci 353:821–830

    Article  PubMed  CAS  Google Scholar 

  32. Gu Y, Wu ZH (2002) The anabolic effects of recombinant human growth hormone and glutamine on parenterally fed, short bowel rats. World J Gastroenterol 8:752–757

    PubMed  CAS  Google Scholar 

  33. Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ (1996) Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-I administration. Am J Physiol 271:G866–G875

    PubMed  CAS  Google Scholar 

  34. Alexander AN, Carey HV (2002) Insulin-like growth factor-I stimulates Na+-dependent glutamine absorption in piglet enterocytes. Dig Dis Sci 47:1129–1134

    Article  PubMed  CAS  Google Scholar 

  35. Ray EC, Avissar NE, Sax HC (2002) Growth factor regulation of enterocyte nutrient transport during intestinal adaptation. Am J Surg 183:361–371

    Article  PubMed  CAS  Google Scholar 

  36. Mithieux G (2001) New data and concepts on glutamine and glucose metabolism in the gut. Curr Opin Clin Nutr Metab Care 4:267–271

    Article  PubMed  CAS  Google Scholar 

  37. Kudsk KA (2002) Current aspects of mucosal immunology and its influence by nutrition. Am J Surg 183:390–398

    Article  PubMed  Google Scholar 

  38. Keefe DM, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47:632–637

    Article  PubMed  CAS  Google Scholar 

  39. Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC (2000) Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J Gastrointest Surg 4:416–423

    Article  PubMed  CAS  Google Scholar 

  40. Fuchs BC, Bode BP (2005) Stressing out over survival: glutamine as an apoptotic modulator. J Surg Res 131:26–40

    Google Scholar 

  41. Curi R, Lagranha CJ, Doi SQ, Sellitti DF, Procopio J, Pithon-Curi TC, Corless M, Newsholme P (2005) Molecular mechanisms of glutamine action. J Cell Physiol 204:392–401

    Article  PubMed  CAS  Google Scholar 

  42. Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC (2000) Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J Gastrointest Surg 4:416–423

    Article  PubMed  CAS  Google Scholar 

  43. Paquette JC, Guerin PJ, Gauthier ER (2005) Rapid induction of the intrinsic apoptotic pathway by L-glutamine starvation. J Cell Physiol 202:912–921

    Article  PubMed  CAS  Google Scholar 

  44. Mates JM, Segura JA, Alonso FJ, Marquez J (2006) Pathways from glutamine to apoptosis. Front Biosci 11:3164–3180

    Article  PubMed  CAS  Google Scholar 

  45. Kircher B, Eibl G, Enrich B, Latzer K, Herold M, Niederwieser D (2002) The role of L-alanyl-L-glutamine in the immune response in vitro. Wien Klin Wochenschr 114:702–708

    PubMed  CAS  Google Scholar 

  46. Brito GA, Carneiro-Filho B, Oria RB, Destura RV, Lima AA, Guerrant RL (2005) Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig Dis Sci 50:1271–1278

    Article  PubMed  CAS  Google Scholar 

  47. Carneiro BA, Fujii J, Brito GA, Alcantara C, Oria RB, Lima AA, Obrig T, Guerrant RL (2006) Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect Immun 74:81–87

    Article  PubMed  CAS  Google Scholar 

  48. Papaconstantinou HT, Chung DH, Zhang W, Ansari NH, Hellmich MR, Townsend CM Jr, Ko TC (2000) Prevention of mucosal atrophy: role of glutamine and caspases in apoptosis in intestinal epithelial cells. J Gastrointest Surg 4:416–423

    Article  PubMed  CAS  Google Scholar 

  49. Evans ME, Jones DP, Ziegler TR (2003) Glutamine prevents cytokine-induced apoptosis in human colonic epithelial cells. J Nutr 133:3065–3071

    PubMed  CAS  Google Scholar 

  50. Decker GM (2002) Glutamine: indicated in cancer care? Clin J Oncol Nurs 6:112–115

    Article  PubMed  Google Scholar 

  51. Brito GA, Carneiro-Filho B, Oria RB, Destura RV, Lima AA, Guerrant RL (2005) Clostridium difficile toxin A induces intestinal epithelial cell apoptosis and damage: role of Gln and Ala-Gln in toxin A effects. Dig Dis Sci 50:1271–1278

    Article  PubMed  CAS  Google Scholar 

  52. Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, Liu Y, Boyle B, Park E, Emtage P, Funk WD, Tomizuka K (2005) Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309:1256–1259

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by the following grants from the National Institutes of Health: ABC Grant no. 5 D43 TW001136, and GIDRT Grant no. 5 D43 TW006578.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard L. Guerrant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braga-Neto, M.B., Warren, C.A., Oriá, R.B. et al. Alanyl-Glutamine and Glutamine Supplementation Improves 5-Fluorouracil-Induced Intestinal Epithelium Damage In Vitro. Dig Dis Sci 53, 2687–2696 (2008). https://doi.org/10.1007/s10620-008-0215-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0215-0

Keywords

Navigation